Advertisement

Topics

Xenova Group PLC Company Profile

13:27 EDT 29th May 2017 | BioPortfolio

Xenova Group plc is an emerging pharmaceutical group, specialising in the development of new small molecule drugs. The company’s strategy is to develop commercially attractive new drugs, primarily in the area of cancer therapeutics.

Location

240 Bath Road
Slough
Berkshire
SL1 4EF
United Kingdom

Contact

Phone: 44 0 1753 706 600
Fax: 44 0 1753 706 615


News Articles [582 Associated News Articles listed on BioPortfolio]

PharmaLex Group acquires The Degge Group

The PharmaLex Group, provider of development consulting and scientific affairs, regulatory affairs and pharmacovigilance, has completed the formal merger with The Degge Group, Ltd.  The company is ba...

ELC Group partners with PSR Group for advanced drug development

Global life sciences partner ELC Group is collaborating with New Zealand-based research and development firm Pharma Scientific Research (PSR Group) to create highly advanced products for the pharmaceu...

HCA Selects Healthcare Marketing Firm to Promote Its Greater Houston Physician Group of More ...

The Weinbach Group Will Use Digital and Conventional Approaches to Grow Patient Volumes MIAMI, FL--(Marketwired - Jan 11, 2017) - The Weinbach Group, a leading Read more...

China’s Youngest Self-Made Billionaire Completes Series A Round In California Healthcom Group

Los Angeles, CA (PRWEB) March 23, 2017 Hakim Unique Group (HUG) just closed a Series A funding investment in Los Angeles based healt...

Lufthansa und Boeing vs. Kuoni und Lockheed Martin - kommentierter KW 4 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: Lufthansa 5,33% vor Boeing 5,12%, FACC 4,23%, TUI AG 4,13%, Flughafen Wien 3,2%, Fraport 1,47%, Thomas Cook Group 1,26%, Air Berlin 0,34%, Airbus Group -0,99%, Lockhee...

Air Berlin und Boeing vs. Kuoni und Thomas Cook Group - kommentierter KW 51 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: Air Berlin 12,86% vor Boeing 2,14%, TUI AG 1,02%, Flughafen Wien 0,43%, FACC -0,17%, Lockheed Martin -0,2%, Lufthansa -0,35%, Fraport -0,96%, Airbus Group -1,73%, Thom...

BRIEF-Tissue Regenix Group names new group finance director

* Appointment of Paul Devlin as group finance director and company secretary with immediate effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Flughafen Wien und Fraport vs. Kuoni und Boeing - kommentierter KW 12 Peer Group Watch Luftfahrt & Reise

In der Wochensicht ist vorne: Flughafen Wien 5,28% vor Fraport 3,49%, Airbus Group 0,52%, Air Berlin 0,18%, Thomas Cook Group 0%, Lufthansa -1,54%, FACC -1,55%, TUI AG -1,56%, Lockheed Martin -1,68...

PubMed Articles [2493 Associated PubMed Articles listed on BioPortfolio]

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Effects of leptin on femoral fracture in rats.

In this study, our objective was to evaluate effects of leptin on fracture healing in rats. Seventy two male Sprague-Dawley (SD) rats were randomized into 3 groups. Standardized femoral fractures were...

Keeping up appearances: Strategic information exchange by disidentified group members.

Information exchange is a crucial process in groups, but to date, no one has systematically examined how a group member's relationship with a group can undermine this process. The current research exa...

Principles of Psychodynamic Group Psychotherapy.

This paper describes different historical developments of the application of psychodynamic treatments within groups and shows some factors reflecting significant influences on the outcome of group psy...

Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats.

This study was designed to investigate whether dexmedetomidine and thiopental have cerebral protective effects after focal cerebral ischemia in rats. Thirty male Sprague Dawley rats were randomly assi...

Clinical Trials [2894 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1554 Associated Companies listed on BioPortfolio]

Xenova Group PLC

Xenova Group plc is an emerging pharmaceutical group, specialising in the development of new small molecule drugs. The company’s strategy is to develop commercially attractive new drugs, primarily i...

Xenova

Xenova Group Limited, a fully-owned subsidiary of Celtic Pharma Development plc, is a UK-based biopharmaceutical company focused on the development of novel drugs to treat cancer and addiction with a ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Xenova Group PLC" on BioPortfolio

We have published hundreds of Xenova Group PLC news stories on BioPortfolio along with dozens of Xenova Group PLC Clinical Trials and PubMed Articles about Xenova Group PLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xenova Group PLC Companies in our database. You can also find out about relevant Xenova Group PLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record